The T-cells are called chimeric since they have receptors incorporating an intracellular CD3ζ-activating domain with cytotoxic capabilities that trigger cellular apoptosis and an antigen-binding single-chain variable fragment with the ability to bind to cancer-associated antigens for the specific targeting of cancer cells [13]. The gene discussed is CD247; the disease is cancer.